Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 13, 2007
US BioEnergy Corporation
(Exact name of registrant as specified in its charter)
         
South Dakota   001-33203   20-1811472
         
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (IRS Employer
Identification No.)
         
5500 Cenex Drive, Inver Grove Heights, MN
  55077
     
(Address of principal executive offices)
  (Zip Code)
         
Registrant’s telephone number, including area code
  (651) 554-5000
         
         
         
 
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Section 2. Financial Information
Item 2.02. Results of Operations and Financial Condition.
Section 9. Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Exhibit Index
Press Release

Table of Contents

Section 2. Financial Information
Item 2.02. Results of Operations and Financial Condition.
On November 13, 2007, we issued a press release announcing our earnings for the quarter ended September 30, 2007. A copy of our November 13, 2007 press release is attached hereto as exhibit 99.1.
Section 9. Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit Number   Description
99.1
  Press Release, dated November 13, 2007.

 

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  US BIOENERGY CORPORATION
  		 
Date: November 13, 2007  /s/ Gregory S. Schlicht    
  By: Gregory S. Schlicht    
  Its: Vice President, General Counsel
and Corporate Secretary  		 
 

 

Table of Contents

Exhibit Index
     
Exhibit Number   Description
99.1
  Press Release, dated November 13, 2007.

 

US Bioenergy Corp (MM) (NASDAQ:USBE)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse US Bioenergy Corp (MM)
US Bioenergy Corp (MM) (NASDAQ:USBE)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse US Bioenergy Corp (MM)